Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2022-04-07 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate share ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and a SEBI circular. The content is about a specific corporate action related to share certificates, not a financial report, earnings release, or management discussion. It does not contain financial data or results, nor is it an announcement of voting results or capital changes like share issuance or buybacks. The document is a regulatory compliance notification about share certificate issuance, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2022-04-07 English
Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided the enclosed certificate for the quarter ended 31st March 2022 under Regulation 74(5) ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the quarter ended 31st March 2022. It confirms compliance with dematerialisation processes and timelines as per SEBI circulars. The document is a formal certification letter addressed to stock exchanges and does not contain financial statements, management discussion, or detailed report data. It is primarily an attestation/certification document related to regulatory compliance. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as a financial report or other specific filing types.
2022-04-07 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 of the ....
Board/Management Information Classification · 95% confidence The document is a notification addressed to stock exchanges about an upcoming Board of Directors meeting scheduled for April 26, 2022. The purpose of the meeting includes consideration of unaudited financial results for the quarter ended March 31, 2022. The document also mentions the closure of the trading window in relation to the financial results publication. The content is an announcement of a board meeting and related compliance information, not the financial results report itself or detailed financial data. The document length is short (1805 characters), and it serves as an official intimation to the stock exchanges rather than a report or detailed filing. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of board meetings and related management information.
2022-04-07 English
General updates
Notice of Dividend Amount Classification · 95% confidence The document is a detailed communication from Sanofi India Limited regarding the deduction of tax at source (TDS) on dividends. It includes information about dividend declaration, payment dates, tax deduction rules for resident and non-resident shareholders, and instructions for submitting tax-related forms (Form 15G, 15H, 10F). The document references the dividend for the year ended 31 December 2021 and the upcoming Annual General Meeting on 26 April 2022 where the dividend will be declared. It is a communication to shareholders about tax deduction on dividends rather than a financial report or earnings release. It does not contain financial statements or earnings data but focuses on dividend payment and tax withholding details. This fits the category of Notice of Dividend Amount (DIV), which covers announcements of dividend amounts, payment dates, and related shareholder information.
2022-04-06 English
Please find enclosed copy of the letter on the above subject sent to the shareholders on 6th April 2022 through email who have registered their email ID with the Company / Depositories.
Notice of Dividend Amount Classification · 95% confidence The document is a detailed communication from Sanofi India Limited regarding the deduction of tax at source (TDS) on dividends. It includes information about dividend payments recommended by the Board of Directors, the tax deduction rules applicable to resident and non-resident shareholders, and instructions for submitting relevant tax forms (Form 15G, 15H, 10F). The document references the dividend for the year ended 31 December 2021 and the upcoming Annual General Meeting on 26 April 2022 where the dividend will be declared. It is a communication to shareholders about dividend tax deduction procedures and compliance, not a financial report or earnings release. It does not contain financial statements or earnings highlights but rather tax-related instructions and regulatory compliance information. This fits the category of Notice of Dividend Amount (DIV), as it relates to dividend payment details and tax deduction notices to shareholders.
2022-04-06 English
Newspaper Advertisements
AGM Information Classification · 95% confidence The document contains a notice of the Annual General Meeting (AGM) and e-voting information published by Sanofi India Limited, dated 5th April 2022. It includes details about the notice publication and voting instructions, which are typical materials shared for an AGM. There is no detailed financial data, management discussion, or full report content. The document also includes various public notices unrelated to financial reporting. The primary focus is on the AGM notice and related voting information, fitting the category of AGM Information (AGM-R). The document length is sufficient to contain the notice but does not constitute a full annual report or other financial filings.
2022-04-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.